Oppenheimer & Co’s Celestica CLS Stock Holding History

Oppenheimer & Co’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$870K	Sell	2,385 -246	-9%	-$92.3K	0.01%	1002
2026 Q1	$741K	Sell	2,631 -223	-8%	-$64.7K	0.01%	1013
2025 Q4	$844K	Sell	2,854 -3,065	-52%	-$924K	0.01%	872
2025 Q3	$1.46M	Sell	5,919 -8,126	-58%	-$1.64M	0.02%	721
2025 Q2	$2.19M	Buy	14,045 +10,160	+262%	+$1.08M	0.03%	546
2025 Q1	$306K	Sell	3,885 -12,565	-76%	-$1.33M	﹤0.01%	1264
2024 Q4	$1.52M	Buy	16,450 +4,874	+42%	+$381K	0.02%	639
2024 Q3	$592K	Sell	11,576 -24,199	-68%	-$1.25M	0.01%	979
2024 Q2	$2.05M	Buy	+35,775	New	+$1.8M	0.03%	528

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Oppenheimer & Co's CLS Position: Q2 2026 in Review

Oppenheimer & Co reduced its Celestica (CLS) stake by 9.4% in Q2 2026, selling an estimated $92.3K and leaving 2,385 shares worth $870K. The position accounts for 0.01% of the portfolio, ranked #1002.

Oppenheimer & Co first reported a position in CLS in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.19M in Q2 2025. 878 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

Oppenheimer & Co held 2,385 shares of Celestica worth $870K as of Q2 2026.
Oppenheimer & Co sold 246 Celestica shares in Q2 2026, an estimated $92.3K.
Celestica made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1002 holding.
Oppenheimer & Co first reported a position in Celestica in Q2 2024 and has held it in 9 quarters since.
Oppenheimer & Co's Celestica position peaked at $2.19M in Q2 2025.
878 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.